STORY AT-A-GLANCE<\/h3>\n\n\n- Dr. Peter Lurie, president of the Center for Science in the Public Interest (CSPI), and Beth Ellikidis, vice president of agriculture and environment at the Biotechnology Innovation Organization (BIO), argue for the genetic engineering of food. Both are connected to Bill Gates and other Great Resetters that are pushing to replace all natural foods with patentable, genetically modified foods<\/span><\/li>\n
- BIO, the world\u2019s largest GMO trade organization, represents more than 1,000 pesticide, pharmaceutical and biotech companies in more than 30 countries. BIO claims genetic engineering is the solution to heal, fuel and feed the world, and to that end, it lobbies 15 different policy areas, including food, agriculture, and health care policy<\/span><\/li>\n
- In 2004, BIO launched BIO Ventures for Global Health (BVGH), a nonprofit organization that \u201cdevelops and manages programs across the for-profit and non-profit sectors to accelerate research and development for poverty-related diseases.\u201d BVGH was launched with a $1 million start-up grant from the Bill & Melinda Gates Foundation<\/span><\/li>\n
- In 2018, the Bill & Melinda Gates Foundation spun off a nonprofit subsidiary to the foundation called the Bill & Melinda Gates Medical Research Institute (Gates MRI), which develops biotechnologies to address health problems in poor countries<\/span><\/li>\n
- BIO is partnered with the U.S. Department of Defense (DOD), and the DOD specifically funds and provides technology transfers for the diseases that Gates MRI and BVGH are focused on: malaria, tuberculosis and Ebola<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n
In an April 17, 2023, opinion piece in STAT News,1<\/span><\/sup>\u00a0Dr. Peter Lurie and Beth Ellikidis argue for the genetic engineering of food, claiming \u201cnewer technologies can make highly targeted changes at the base-pair level \u2014 one specific rung on the DNA ladder \u2014 enhancing precision and reducing the likelihood of \u2018off-target effects\u2019 in which the base pairs are unintentionally added to or deleted from the genome.\u201d<\/p>\nWhile targeted genetic engineering is indeed possible, and modern technology lowers the likelihood of unintentional additions or deletions, this precision does not guarantee there won\u2019t be adverse effects. One of the reasons for this is because many genes are multifunctional and can have multiple downstream effects.2<\/span>,3<\/span><\/sup><\/p>\nBy altering a single gene, you can inadvertently affect the expression of hundreds of others. What\u2019s more, the multifunctionality of genes is rarely intuitive. So, while it may seem convenient to genetically engineer cows without horns to prevent injury to other cows and farmhands, as suggested by Lurie and Ellikidis, there\u2019s no telling what that tweak might do to internal organs or biological pathways.<\/p>\n
In turn, there\u2019s no guarantee that cascading effects will not alter the nutrition of the meat or dairy that comes from that cow. Maybe it\u2019ll be fine, maybe it won\u2019t. The problem is that, oftentimes with genetically engineered foods, safety testing is minimal or absent.<\/p>\n
Who Do Lurie and Ellikidis Answer To?<\/h2>\n
When assessing the trustworthiness of people, it can be worthwhile to look at their funding and various partnerships. In the case of Lurie and Ellikidis, both are in league with Bill Gates and other Great Resetters that are pushing to replace all natural foods with patentable, genetically modified foods.<\/p>\n
<\/div>\nLurie \u2014 a former FDA associate commissioner \u2014 is the president of the\u00a0Center for Science in the Public Interest (CSPI)<\/a>. In the summer of 2020, Lurie launched a comprehensive campaign to put Mercola.com out of business by sending the U.S. Food and Drug Administration and the Federal Trade Commission after us based on bogus charges.<\/p>\nCSPI is funded by the Rockefeller Foundation, the Rockefeller Family Fund, Bloomberg Philanthropies and other billionaire-owned foundations. It\u2019s also partnered with the Cornell Alliance for Science, a \u201cglobal communications initiative\u201d whose primary funding comes from the Bill & Melinda Gates Foundation. Greg Jaffe, who heads up CSPI\u2019s Biotechnology Project, is also the associate director of legal affairs at Alliance for Science.<\/p>\n
Considering those ties, the CSPI\u2019s long history of promoting industry science and propaganda is not surprising in the least. They supported artificial sweeteners, trans fats, GMOs, fake meat and the low-fat myth. They\u2019ve also actively undermined transparency in labeling efforts.<\/p>\n
Ellikidis, meanwhile, is the vice president of agriculture and environment at the Biotechnology Innovation Organization (BIO). She\u2019s leading the \u201cpolicy and market access strategies for BIO\u2019s Agriculture and Environment section, which includes member companies developing and producing breakthrough technologies in food and agriculture.\u201d4<\/span><\/sup><\/p>\nBIO, the world\u2019s largest GMO trade organization,5<\/span>,6<\/span><\/sup>\u00a0represents more than 1,000 pesticide, pharmaceutical and biotech companies in more than 30 countries, as well as industry groups, academic institutions, state biotechnology centers and other related organizations.<\/p>\nAccording to BIO, genetic engineering is the solution to heal, fuel and feed the world, and to that end, it has lobbying committees dedicated to influencing 15 different policy areas, including food, agriculture, health care policy, technology transfer and finance.<\/p>\n
According to Open Secrets,7<\/span><\/sup>\u00a0BIO spent $13,250,000 on \u201cpharmaceutical and health products\u201d lobbying in 2022. For reference, only Pfizer and the lobbying group Pharmaceutical Research and Manufacturers of America spent more.8<\/span><\/sup><\/p>\n<\/div>\nHow Gates Sets Himself Up for Success<\/h2>\n
In 2004, BIO launched BIO Ventures for Global Health (BVGH),9<\/span><\/sup>\u00a0a nonprofit organization that \u201cstrategically develops and manages programs across the for-profit and non-profit sectors to accelerate research and development (R&D) for poverty-related diseases.\u201d<\/p>\nBVGH was launched with a $1 million start-up grant from the Bill & Melinda Gates Foundation.10<\/span><\/sup>\u00a0In 2005, the BVGH received another $5.4 million to expand the biotech industry\u2019s role in the fight against neglected diseases.11<\/span><\/sup>\u00a0The Rockefeller Foundation is also funding the group.<\/p>\nFast-forward to 2018, and the Bill & Melinda Gates Foundation spun off a nonprofit subsidiary to the foundation called the Bill & Melinda Gates Medical Research Institute (Gates MRI).12<\/span><\/sup>\u00a0Gates MRI, funded with a $273 million, four-year grant from the Gates Foundation, is focused on developing biotechnologies to address health problems in poor countries.13<\/span><\/sup><\/p>\nIt\u2019s a convenient setup to say the least. On the one hand, Gates is funding the R&D of biotech products through Gates MRI, and on the other, he\u2019s funding the acceleration, coordination and management of private-public biotech programs through BVGH.<\/p>\n
One key area where the BVGH is being inserted to manage private-public programs is the \u201cCancer Moonshot\u201d program, launched in 2016 by then-Vice President Joe Biden. Biden \u201creignited\u201d and highlighted the program in 2022.14<\/span><\/sup>\u00a0As reported in a White House fact sheet:15<\/span><\/sup><\/p>\n\u201cWorking with African Access Initiative (AAI) partners, BIO Ventures for Global Health (BVGH) will implement cancer research projects that are determined and led by African oncologists and conducted in collaboration with U.S. cancer experts.<\/em><\/p><\/blockquote>\nThrough its African Consortium for Cancer Clinical Trials (AC3<\/sup>T) program, BVGH will facilitate five research projects, build capacity to conduct rigorous clinical research at 50 African sites, promote African primary investigator\u2019s research interests on the AC3<\/sup>T platform, and coordinate the implementation of observational clinical studies.<\/em><\/p><\/blockquote>\nIn addition to building AC3<\/sup>T sites\u2019 research capacity, BVGH will map the regulatory pathway in five AAI countries. All clinical studies involving cancer drugs will include development of market access pathways by BVGH.\u201d<\/em><\/p><\/blockquote>\nGates MRI, in turn, intends to \u201capply new understanding of the human immune system learned from cancer research to prevent infectious disease.\u201d16<\/span><\/sup>\u00a0Conveniently, he\u2019s got the inside track to all of that through the BVGH.<\/p>\n![](\"https:\/\/media.mercola.com\/assets\/images\/mercola\/pdf\/pdf-download-desktop.png\")
<\/p>\n\nDownload this Article Before it Disappears<\/h3>\n
Download PDF<\/a><\/div>\n<\/div>\nBiowarfare Partners<\/h2>\n\n
- \n
- Dr. Peter Lurie, president of the Center for Science in the Public Interest (CSPI), and Beth Ellikidis, vice president of agriculture and environment at the Biotechnology Innovation Organization (BIO), argue for the genetic engineering of food. Both are connected to Bill Gates and other Great Resetters that are pushing to replace all natural foods with patentable, genetically modified foods<\/span><\/li>\n
- BIO, the world\u2019s largest GMO trade organization, represents more than 1,000 pesticide, pharmaceutical and biotech companies in more than 30 countries. BIO claims genetic engineering is the solution to heal, fuel and feed the world, and to that end, it lobbies 15 different policy areas, including food, agriculture, and health care policy<\/span><\/li>\n
- In 2004, BIO launched BIO Ventures for Global Health (BVGH), a nonprofit organization that \u201cdevelops and manages programs across the for-profit and non-profit sectors to accelerate research and development for poverty-related diseases.\u201d BVGH was launched with a $1 million start-up grant from the Bill & Melinda Gates Foundation<\/span><\/li>\n
- In 2018, the Bill & Melinda Gates Foundation spun off a nonprofit subsidiary to the foundation called the Bill & Melinda Gates Medical Research Institute (Gates MRI), which develops biotechnologies to address health problems in poor countries<\/span><\/li>\n
- BIO is partnered with the U.S. Department of Defense (DOD), and the DOD specifically funds and provides technology transfers for the diseases that Gates MRI and BVGH are focused on: malaria, tuberculosis and Ebola<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\nIn an April 17, 2023, opinion piece in STAT News,1<\/span><\/sup>\u00a0Dr. Peter Lurie and Beth Ellikidis argue for the genetic engineering of food, claiming \u201cnewer technologies can make highly targeted changes at the base-pair level \u2014 one specific rung on the DNA ladder \u2014 enhancing precision and reducing the likelihood of \u2018off-target effects\u2019 in which the base pairs are unintentionally added to or deleted from the genome.\u201d<\/p>\n
While targeted genetic engineering is indeed possible, and modern technology lowers the likelihood of unintentional additions or deletions, this precision does not guarantee there won\u2019t be adverse effects. One of the reasons for this is because many genes are multifunctional and can have multiple downstream effects.2<\/span>,3<\/span><\/sup><\/p>\n
By altering a single gene, you can inadvertently affect the expression of hundreds of others. What\u2019s more, the multifunctionality of genes is rarely intuitive. So, while it may seem convenient to genetically engineer cows without horns to prevent injury to other cows and farmhands, as suggested by Lurie and Ellikidis, there\u2019s no telling what that tweak might do to internal organs or biological pathways.<\/p>\n
In turn, there\u2019s no guarantee that cascading effects will not alter the nutrition of the meat or dairy that comes from that cow. Maybe it\u2019ll be fine, maybe it won\u2019t. The problem is that, oftentimes with genetically engineered foods, safety testing is minimal or absent.<\/p>\n
Who Do Lurie and Ellikidis Answer To?<\/h2>\n
When assessing the trustworthiness of people, it can be worthwhile to look at their funding and various partnerships. In the case of Lurie and Ellikidis, both are in league with Bill Gates and other Great Resetters that are pushing to replace all natural foods with patentable, genetically modified foods.<\/p>\n
<\/div>\nLurie \u2014 a former FDA associate commissioner \u2014 is the president of the\u00a0Center for Science in the Public Interest (CSPI)<\/a>. In the summer of 2020, Lurie launched a comprehensive campaign to put Mercola.com out of business by sending the U.S. Food and Drug Administration and the Federal Trade Commission after us based on bogus charges.<\/p>\n
CSPI is funded by the Rockefeller Foundation, the Rockefeller Family Fund, Bloomberg Philanthropies and other billionaire-owned foundations. It\u2019s also partnered with the Cornell Alliance for Science, a \u201cglobal communications initiative\u201d whose primary funding comes from the Bill & Melinda Gates Foundation. Greg Jaffe, who heads up CSPI\u2019s Biotechnology Project, is also the associate director of legal affairs at Alliance for Science.<\/p>\n
Considering those ties, the CSPI\u2019s long history of promoting industry science and propaganda is not surprising in the least. They supported artificial sweeteners, trans fats, GMOs, fake meat and the low-fat myth. They\u2019ve also actively undermined transparency in labeling efforts.<\/p>\n
Ellikidis, meanwhile, is the vice president of agriculture and environment at the Biotechnology Innovation Organization (BIO). She\u2019s leading the \u201cpolicy and market access strategies for BIO\u2019s Agriculture and Environment section, which includes member companies developing and producing breakthrough technologies in food and agriculture.\u201d4<\/span><\/sup><\/p>\n
BIO, the world\u2019s largest GMO trade organization,5<\/span>,6<\/span><\/sup>\u00a0represents more than 1,000 pesticide, pharmaceutical and biotech companies in more than 30 countries, as well as industry groups, academic institutions, state biotechnology centers and other related organizations.<\/p>\n
According to BIO, genetic engineering is the solution to heal, fuel and feed the world, and to that end, it has lobbying committees dedicated to influencing 15 different policy areas, including food, agriculture, health care policy, technology transfer and finance.<\/p>\n
According to Open Secrets,7<\/span><\/sup>\u00a0BIO spent $13,250,000 on \u201cpharmaceutical and health products\u201d lobbying in 2022. For reference, only Pfizer and the lobbying group Pharmaceutical Research and Manufacturers of America spent more.8<\/span><\/sup><\/p>\n
<\/div>\nHow Gates Sets Himself Up for Success<\/h2>\n
In 2004, BIO launched BIO Ventures for Global Health (BVGH),9<\/span><\/sup>\u00a0a nonprofit organization that \u201cstrategically develops and manages programs across the for-profit and non-profit sectors to accelerate research and development (R&D) for poverty-related diseases.\u201d<\/p>\n
BVGH was launched with a $1 million start-up grant from the Bill & Melinda Gates Foundation.10<\/span><\/sup>\u00a0In 2005, the BVGH received another $5.4 million to expand the biotech industry\u2019s role in the fight against neglected diseases.11<\/span><\/sup>\u00a0The Rockefeller Foundation is also funding the group.<\/p>\n
Fast-forward to 2018, and the Bill & Melinda Gates Foundation spun off a nonprofit subsidiary to the foundation called the Bill & Melinda Gates Medical Research Institute (Gates MRI).12<\/span><\/sup>\u00a0Gates MRI, funded with a $273 million, four-year grant from the Gates Foundation, is focused on developing biotechnologies to address health problems in poor countries.13<\/span><\/sup><\/p>\n
It\u2019s a convenient setup to say the least. On the one hand, Gates is funding the R&D of biotech products through Gates MRI, and on the other, he\u2019s funding the acceleration, coordination and management of private-public biotech programs through BVGH.<\/p>\n
One key area where the BVGH is being inserted to manage private-public programs is the \u201cCancer Moonshot\u201d program, launched in 2016 by then-Vice President Joe Biden. Biden \u201creignited\u201d and highlighted the program in 2022.14<\/span><\/sup>\u00a0As reported in a White House fact sheet:15<\/span><\/sup><\/p>\n
\u201cWorking with African Access Initiative (AAI) partners, BIO Ventures for Global Health (BVGH) will implement cancer research projects that are determined and led by African oncologists and conducted in collaboration with U.S. cancer experts.<\/em><\/p><\/blockquote>\n
Through its African Consortium for Cancer Clinical Trials (AC3<\/sup>T) program, BVGH will facilitate five research projects, build capacity to conduct rigorous clinical research at 50 African sites, promote African primary investigator\u2019s research interests on the AC3<\/sup>T platform, and coordinate the implementation of observational clinical studies.<\/em><\/p><\/blockquote>\n
In addition to building AC3<\/sup>T sites\u2019 research capacity, BVGH will map the regulatory pathway in five AAI countries. All clinical studies involving cancer drugs will include development of market access pathways by BVGH.\u201d<\/em><\/p><\/blockquote>\n
Gates MRI, in turn, intends to \u201capply new understanding of the human immune system learned from cancer research to prevent infectious disease.\u201d16<\/span><\/sup>\u00a0Conveniently, he\u2019s got the inside track to all of that through the BVGH.<\/p>\n
<\/p>\n\nDownload this Article Before it Disappears<\/h3>\n
Download PDF<\/a><\/div>\n<\/div>\n
Biowarfare Partners<\/h2>\n
\n - BIO, the world\u2019s largest GMO trade organization, represents more than 1,000 pesticide, pharmaceutical and biotech companies in more than 30 countries. BIO claims genetic engineering is the solution to heal, fuel and feed the world, and to that end, it lobbies 15 different policy areas, including food, agriculture, and health care policy<\/span><\/li>\n